starpharma | home
home
about starpharma
technology
product pipeline
news room
investor relations
 careers contact us
site search
News Room
 
 
 June 2009
Appendix 3B - Employee Share Options
30/06/2009
Lapse of Unquoted Options
30/06/2009
Shareholder Update June 2009
2/06/2009
 May 2009
Change in substantial holding
25/05/2009
Cleansing Statement
22/05/2009
Appendix 3B
22/05/2009
Appendix 3B
22/05/2009
Completes $7.1m capital raising
21/05/2009
CEO Investor Presentation
13/05/2009
Elanco Deal Triggers Starpharma SPP Extension
11/05/2009
Starpharma and Elanco Sign Agreement
11/05/2009
Share Purchase Plan Extension
5/05/2009
 April 2009
Shareholder Update May 2009
30/04/2009
Share Purchase Plan
22/04/2009
Change in Substantial Holding
16/04/2009
Cleansing Statement
8/04/2009
Appendix 3B
8/04/2009
Appendix 4C - Quarterly Report
7/04/2009
Raises Additional Capital via Institutional Placement
7/04/2009
Trading Halt
3/04/2009
 March 2009
Completes patient testing in retention of activity study
19/03/2009
 February 2009
2008 Half Yearly Report and Half Year Accounts (0.2MB)
19/02/2009
Topical Microbicide Field Boost With Efficacy Result
10/02/2009
Lapse of unquoted options
9/02/2009
 January 2009
Appendix 4C - Quarterly Report
30/01/2009
 December 2008
Appendix 3B Employee and consultant share options
24/12/2008
Lapse of share options
24/12/2008
Starpharma Dendrimer Reduces Toxicity of Cancer Drug
17/12/2008
Shareholder Update December 2008
8/12/2008
SPL7013 activity against all major HPV strains
4/12/2008
 November 2008
Results of Meeting
17/11/2008
AGM Chair Address and CEO Presentation
14/11/2008
 October 2008
Quarterly Cashflow Report
31/10/2008
Key VivaGel Patent Approved in Japan
30/10/2008
Notice of Annual General Meeting/Proxy Form
14/10/2008
Release of shares from escrow and Form 605
1/10/2008
 September 2008
2008 Annual Report (2.5MB)
29/09/2008
CEO Presentation San Francisco Investor Summit
15/09/2008
VivaGel Condom Full Licence Agreement with Durex
9/09/2008
Change of Director Interest Notice R Hazleton
5/09/2008
Change of Director Interest Notice J Raff
5/09/2008
 August 2008
Change of Director Interest Notice Dr J Raff
29/08/2008
Preliminary Final Report
27/08/2008
VivaGel - New Clinical Trial Commences
13/08/2008
 July 2008
Appendix 4C - Quarterly Report
30/07/2008
Change of Director`s Interest Notice
24/07/2008
New Indication for VivaGel - Bacterial Vaginosis Treatment
9/07/2008